Based on the frequency of CTNNB1 mutated tumours in NSMP group (26–52%) with independent prognostic value, some authors propose CTNNB1–mutated ECs may be regarded as a fifth molecular subgroup [53, 54]. This evidence concerns the gene CTNNB1 and neoplasm.